8-K
Current Report
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001048477-24-000132
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading bmrn-20240823.htm…